back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-05-21 16:27 Tx date 2026-05-20 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,044
+97,515 vol $0.103 each |
4,425,000 | |
| Filed 2026-05-21 16:27 Tx date 2026-05-19 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$255.95
+2,485 vol $0.103 each |
4,327,485 | |
| Filed 2026-05-21 16:26 Tx date 2026-05-18 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,300
+100,000 vol $0.103 each |
4,325,000 | |
| Filed 2026-05-21 16:20 Tx date 2026-05-21 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$577.50
+5,500 vol $0.105 each |
6,001,000 | |
| Filed 2026-05-21 16:19 Tx date 2026-05-21 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,219
+11,399 vol $0.107 each |
5,995,500 | |
| Filed 2026-05-21 16:18 Tx date 2026-05-20 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,000
+200,000 vol $0.105 each |
5,984,101 | |
| Filed 2026-05-14 16:22 Tx date 2026-05-13 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,200
+200,000 vol $0.106 each |
4,225,000 | |
| Filed 2026-05-14 16:21 Tx date 2026-05-12 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,500
+100,000 vol $0.105 each |
4,025,000 | |
| Filed 2026-05-11 16:34 Tx date 2026-05-11 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$44,197
+391,129 vol $0.113 each |
3,925,000 | |
| Filed 2026-05-11 16:33 Tx date 2026-05-08 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,193
+108,871 vol $0.112 each |
3,533,871 | |
| Filed 2026-05-08 16:10 Tx date 2026-05-08 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,500
+250,000 vol $0.11 each |
1,250,000 | |
| Filed 2025-11-18 17:46 Tx date 2025-11-17 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
56 - Grant of rights
|
$197,503
+1,975,033 vol $0.10 each |
3,950,066 | |
| Filed 2025-11-18 17:44 Tx date 2024-11-11 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
56 - Grant of rights
|
$256,754
+1,975,033 vol $0.13 each |
1,975,033 | |
| Filed 2025-11-18 17:42 Tx date 2016-04-21 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-18 17:36 Tx date 2025-11-17 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Whelan, Sean
4 - Director of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
56 - Grant of rights
|
$197,503
+1,975,033 vol $0.10 each |
3,950,066 | |
| Filed 2025-11-18 17:34 Tx date 2024-11-11 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Whelan, Sean
4 - Director of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
56 - Grant of rights
|
$256,754
+1,975,033 vol $0.13 each |
1,975,033 | |
| Filed 2025-11-18 17:33 Tx date 2021-09-13 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Whelan, Sean
4 - Director of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-18 17:29 Tx date 2025-11-17 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights (Stock Appreciation Rights)
56 - Grant of rights
|
$212,695
+2,126,959 vol $0.10 each |
4,253,918 | |
| Filed 2025-11-18 17:27 Tx date 2024-11-11 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights (Stock Appreciation Rights)
56 - Grant of rights
|
$276,504
+2,126,959 vol $0.13 each |
2,126,959 | |
| Filed 2025-11-18 17:26 Tx date 2016-04-21 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights (Stock Appreciation Rights)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-18 17:23 Tx date 2025-11-17 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
56 - Grant of rights
|
$182,310
+1,823,107 vol $0.10 each |
3,646,214 | |
| Filed 2025-11-18 17:21 Tx date 2024-11-11 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
56 - Grant of rights
|
$237,003
+1,823,107 vol $0.13 each |
1,823,107 | |
| Filed 2025-11-18 17:20 Tx date 2020-06-16 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-18 17:15 Tx date 2025-11-17 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
MacLeod, Christopher
4 - Director of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
56 - Grant of rights
|
$182,310
+1,823,107 vol $0.10 each |
3,646,214 | |
| Filed 2025-11-18 17:14 Tx date 2024-11-11 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
MacLeod, Christopher
4 - Director of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
56 - Grant of rights
|
$237,003
+1,823,107 vol $0.13 each |
1,823,107 | |
| Filed 2025-11-18 17:12 Tx date 2020-07-09 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
MacLeod, Christopher
4 - Director of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-18 17:08 Tx date 2025-11-17 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Nichols, Pamela Ann
4 - Director of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
56 - Grant of rights
|
$182,310
+1,823,107 vol $0.10 each |
3,798,140 | |
| Filed 2025-11-18 17:07 Tx date 2024-11-11 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Nichols, Pamela Ann
4 - Director of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
56 - Grant of rights
|
$256,754
+1,975,033 vol $0.13 each |
1,975,033 | |
| Filed 2025-11-18 17:06 Tx date 2022-08-23 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Nichols, Pamela Ann
4 - Director of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-18 17:02 Tx date 2025-11-17 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
56 - Grant of rights
|
$182,310
+1,823,107 vol $0.10 each |
3,646,214 | |
| Filed 2025-11-18 17:00 Tx date 2024-11-11 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
56 - Grant of rights
|
$237,003
+1,823,107 vol $0.13 each |
1,823,107 | |
| Filed 2025-11-18 16:59 Tx date 2019-08-16 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Rights (Stock Appreciation Rights)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-14 05:01 Tx date 2025-11-13 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,550
+150,000 vol $0.097 each |
5,784,101 | |
| Filed 2025-11-11 10:37 Tx date 2025-11-10 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,760
+120,000 vol $0.098 each |
5,634,101 | |
| Filed 2025-11-10 17:56 Tx date 2025-11-07 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$475.00
+5,000 vol $0.095 each |
5,514,101 | |
| Filed 2025-11-07 18:36 Tx date 2025-11-06 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,240
+253,007 vol $0.08 each |
5,509,101 | |
| Filed 2025-08-13 14:10 Tx date 2025-08-12 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,813
+745,341 vol $0.04 each |
5,256,094 | |
| Filed 2025-08-13 14:10 Tx date 2025-08-12 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,000
+250,000 vol $0.04 each |
4,510,753 | |
| Filed 2025-08-13 14:09 Tx date 2025-08-11 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,428
+60,723 vol $0.04 each |
4,260,753 | |
| Filed 2025-08-12 14:09 Tx date 2025-08-11 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,000
+250,000 vol $0.04 each |
4,200,030 | |
| Filed 2025-08-12 14:08 Tx date 2025-08-11 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,500
+250,000 vol $0.038 each |
3,950,030 | |
| Filed 2025-08-12 14:06 Tx date 2025-08-08 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,000
+500,000 vol $0.04 each |
3,700,030 | |
| Filed 2025-06-16 17:10 Tx date 2025-06-12 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Blair, Tony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$37,500
+750,000 vol $0.05 each |
4,150,000 | |
| Filed 2025-06-16 17:06 Tx date 2025-06-12 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+500,000 vol $0.05 each |
2,700,000 | |
| Filed 2025-06-16 17:03 Tx date 2025-06-12 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$200,000
+4,000,000 vol $0.05 each |
18,000,000 | |
| Filed 2025-06-16 16:57 Tx date 2025-06-12 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
DeHaan-Fullerton, Karen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+500,000 vol $0.05 each |
1,500,000 | |
| Filed 2025-05-21 16:20 Tx date 2025-05-21 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Blair, Tony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,187
+63,750 vol $0.05 each |
1,000,000 | |
| Filed 2025-05-21 16:19 Tx date 2025-05-21 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Blair, Tony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,776
+36,250 vol $0.049 each |
936,250 | |
| Filed 2025-05-20 16:12 Tx date 2025-05-19 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
DeHaan-Fullerton, Karen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,006
+104,300 vol $0.048 each |
104,300 | |
| Filed 2025-05-20 16:07 Tx date 2025-05-19 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,000
+500,000 vol $0.046 each |
3,425,000 |